Share capital development

The share capital of FRISQ currently amounts to SEK 1,610,239 divided into 32,204,773 shares with a quota value of SEK 0.05. All shares are fully paid and denominated in SEK.

Under the current Articles of Association, adopted at the Extraordinary Annual General Meeting on June 4, 2019, the share capital shall be at least SEK 625,000 and no more than SEK 2,500,000 divided between at least 12,500,000 shares and no more than 50,000,000 shares.

For changes of the company’s share capital and number of shares, see table below:

Registered

Event

Chang in share capital (SEK) Change in total shares Total shares Share quota value (SEK)

Share capital (SEK)

2014-01-22

Formation

50,000 1,000,000 1,000,000 0.05

50,000

2015-07-31

Rights issue

25,000 500,000 1,500,000 0.05

75,000

2015-11-24

Rights issue

50,000 1,000,000 2,500,000 0.05

125,000

2015-11-24

Rights issue

110,256.4 2,205,128 4,705,128 0.05

235,256.4

2015-11-24

Non-cash issue

389,743.6 7,794,872 12,500,000 0.05

625,000

2016-03-31

Rights issue

96,125 1,922,500 14,422,500 0.05

721,125

2017-03-31

Rights issue

120,192 2,403,846 16,826,346 0.05

841,317

2017-10-18

Rights issue

5,000 100,000 16,926,346 0.05

846,317

2018-05-24

Rights issue

139,797 2,795,941 19,722,287 0.05

986,114

2018-10-10

Rights issue

24,796 495,915 20,218,202 0.05

1,010,910

2019-03-26

Rights issue

185,000 3,700,000 23,918,202 0.05

1,195,910

2020-02-25

Rights issue

358,773 7,175,460 31,093,662 0.05

1,554,683

2020-02-25

Oversubscription option

55,556 1,111,111 32,204,773 0.05

1,610,239

The group was formed by previously stated apport issue, whereby all shareholders in the subsidiary FRISQ AB subscribed for new shares in FRISQ Holding for payment in the form of shares in FRISQ AB.

A right issue was performed in March 2017 to finance the start-up and commercialization of the acquired platform FRISQ Care. The new rights issue of 100,000 shares was made as part of the initial purchase price.

A right issue was performed in May 2018 to finance rapid expansion in Sweden and internationally and was directed to well-reputable institutional investors in Sweden.

A right issue was performed in October 2018 with support from the AGM mandate to finance the payment of shares in the subsidiary Frisq AB, shares that had been acquired in accordance with a management incentive program.

A right issue was performed in March 2019 to enable establishment of FRISQ in the US as well as to support the Company’s ongoing development and operations. The rights issue was directed to institutional investors and some current major shareholders.

A rights issue with a related oversubscription option was performed in February 2020 to provide funding for scaling of the product while participating in larger tenders with high long term profitability potential.